VaccImm: Simulating peptide vaccination in cancer therapy

BMC Bioinformatics

Volumn 14, Issue , 2013, Pages

  von Eichborn, Joachim ^a   Woelke, Anna L ^a,b   Castiglione, Filippo ^c   Preissner, Robert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CNR   (Italy)

Author keywords

Cancer; Immunoinformatics; Modelling; Protein interaction; Proteins; Systems biology

Indexed keywords

AGENT-BASED MODEL; AMINO ACID SEQUENCE; CANCER; CONVENTIONAL METHODS; IMMUNOINFORMATICS; INDUSTRIAL NATIONS; PROTEIN INTERACTION; SYSTEMS BIOLOGY;

AMINO ACIDS; BINDING SITES; DISEASES; EPITOPES; IMMUNE SYSTEM; MODELS; ONCOLOGY; POPULATION STATISTICS; PROTEINS; TUMORS; VACCINES;

PEPTIDES;

CANCER VACCINE; EPITOPE; PEPTIDE; SUBUNIT VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; GENOTYPE; HUMAN; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASM; TUMOR VOLUME;

AMINO ACID SEQUENCE; CANCER VACCINES; COMPUTER SIMULATION; EPITOPES; GENOTYPE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASMS; PEPTIDES; SOFTWARE; TUMOR BURDEN; VACCINES, SUBUNIT;

EID: 84876142055     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-14-127     Document Type: Article

References (23)

1. Palucka K, Ueno H, Banchereau J. Recent developments in cancer vaccines. J Immunol 2011, 186:1325-1331. 10.4049/jimmunol.0902539, 3060768, 21248270.
2. Woelke AL, Von Eichborn J, Murgueitio MS, Worth CL, Castiglione F, Preissner R. Development of immune-specific interaction potentials and their application in the multi-agent-system VaccImm. PLoS One 2011, 6:e23257. 10.1371/journal.pone.0023257, 3157361, 21858048.
3. Louzoun Y, Solomon S, Atlan H, Cohen IR. Modeling complexity in biology. Physica A: Stat Mech and its Appl 2001, 297:242-252.
4. Celada F, Seiden PE. A computer model of cellular interactions in the immune system. Immunol Today 1992, 13:56-62. 10.1016/0167-5699(92)90135-T, 1575893.
5. Cheng Y, Ghersi D, Calcagno C, Selin LK, Puzone R, Celada F. A discrete computer model of the immune system reveals competitive interactions between the humoral and cellular branch and between cross-reacting memory and naïve responses. Vaccine 2009, 27:833-845. 10.1016/j.vaccine.2008.11.109, 19101600.
6. Folcik VA, An GC, Orosz CG. The Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunity. Theor Biol Med Model 2007, 4:39. 10.1186/1742-4682-4-39, 2186321, 17900357.
7. Mallet DG, De Pillis LG. A cellular automata model of tumor-immune system interactions. J Theor Biol 2006, 239:334-350. 10.1016/j.jtbi.2005.08.002, 16169016.
8. Castiglione F, Toschi F, Bernaschi M, Succi S, Benedetti R, Falini B, Liso A. Computational modeling of the immune response to tumor antigens. J Theor Biol 2005, 237:390-400. 10.1016/j.jtbi.2005.04.024, 16039673.
9. Pappalardo F, Lollini P-L, Castiglione F, Motta S. Modeling and simulation of cancer immunoprevention vaccine. Bioinformatics 2005, 21:2891-2897. 10.1093/bioinformatics/bti426, 15817697.
10. Rapin N, Lund O, Castiglione F. Immune System Simulation Online. Bioinformatics 2011, 27:2013-2014. 10.1093/bioinformatics/btr335, 21685045.
11. Rapin N, Lund O, Bernaschi M, Castiglione F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One 2010, 5:e9862. 10.1371/journal.pone.0009862, 2855701, 20419125.
12. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, Bui H-H, Grey H, Sette A. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 2006, 24:817-819. 10.1038/nbt1215, 16767078.
13. Nielsen M, Lundegaard C, Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinforma 2007, 8:238.
14. Peters B, Sidney J, Bourne P, Bui H-H, Buus S, Doh G, Fleri W, Kronenberg M, Kubo R, Lund O, Nemazee D, Ponomarenko JV, Sathiamurthy M, Schoenberger S, Stewart S, Surko P, Way S, Wilson S, Sette A. The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol 2005, 3:e91. 10.1371/journal.pbio.0030091, 1065705, 15760272.
15. Jones J, Otu H, Spentzos D, Kolia S, Inan M, Beecken WD, Fellbaum C, Gu X, Joseph M, Pantuck AJ, Jonas D, Libermann TA. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 2005, 11:5730-5739. 10.1158/1078-0432.CCR-04-2225, 16115910.
16. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B. The immune epitope database 2.0. Nucleic Acids Res 2010, 38:D854-D862. 10.1093/nar/gkp1004, 2808938, 19906713.
17. Stevanovic S. Identification of tumour-associated T-cell epitopes for vaccine development. Nat Rev Cancer 2002, 2:514-520. 10.1038/nrc841, 12094237.
18. Nagy G, Emody L, Pál T. Strategies for the development of vaccines conferring broad-spectrum protection. Int J Med Microbiol 2008, 298:379-395. 10.1016/j.ijmm.2008.01.012, 18485818.
19. Ridgway WM, Fathman CG. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. Clin Immunol Immunopathol 1998, 86:3-10. 10.1006/clin.1997.4449, 9434791.
20. Riley EM. The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens. Parasitology 1996, 112(Suppl):S39-S51.
21. Nielsen M, Lund O, Buus S, Lundegaard C. MHC class II epitope predictive algorithms. Immunology 2010, 130:319-328. 10.1111/j.1365-2567.2010.03268.x, 2913211, 20408898.
22. Uhr JW, Scheuermann RH, Street NE, Vitetta ES. Cancer dormancy: opportunities for new therapeutic approaches. Nat Med 1997, 3:505-509. 10.1038/nm0597-505, 9142117.
23. Rayala HJ, Richie JP. Radical prostatectomy reigns supreme. Oncology (Williston Park) 2009, 23:863-867.